Hims & Hers Acquires Eucalyptus for $1.15 Billion to Expand International Telehealth Footprint
Event summary
- Hims & Hers has agreed to acquire Eucalyptus, an Australian digital health provider, for up to $1.15 billion.
- The acquisition will be financed primarily with existing cash and future operating cash flows, with $240 million payable in cash at closing.
- Tim Doyle, current CEO of Eucalyptus, will become SVP of International at Hims & Hers.
- Eucalyptus has an annual revenue run-rate exceeding $450 million USD and has served over 775,000 customers.
- The deal is expected to close in mid-2026 and is subject to customary closing conditions, including regulatory approvals.
The big picture
This acquisition signals Hims & Hers’ aggressive push to become a global consumer health platform, moving beyond its US dominance. The $1.15 billion price tag reflects the growing investor interest in digital health solutions and the increasing demand for accessible, personalized care, particularly in international markets. Eucalyptus’s existing infrastructure and expertise provide a shortcut to expansion, but also introduce integration risks and regulatory hurdles.
What we're watching
- Integration Risk
- Successfully integrating Eucalyptus's operations and brands into Hims & Hers' existing platform will be crucial, and potential cultural clashes or operational inefficiencies could hinder the deal's value creation.
- Regulatory Landscape
- The varying regulatory environments in Australia, Japan, Germany, Canada, and the UK pose a significant challenge, and Hims & Hers will need to navigate these complexities to achieve its international expansion goals.
- Market Adoption
- The pace at which Eucalyptus’s brands and Hims & Hers’ services are adopted by consumers in new international markets will determine the overall success of the acquisition and its impact on profitability.
Related topics